| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Cowen
|
Employee |
18
Very Strong
|
38 | |
|
person
Cowen
|
Employment affiliation |
11
Very Strong
|
19 | |
|
person
Cowen
|
Professional |
7
|
3 | |
|
person
Cowen
|
Employment internal distribution |
7
|
2 | |
|
person
Cowen
|
Employment internal |
6
|
2 | |
|
person
Cowen
|
Client |
6
|
1 | |
|
person
Cowen
|
Professional employment |
6
|
2 | |
|
person
Cowen
|
Employment |
5
|
1 | |
|
person
Cowen and Company
|
Employment affiliation |
5
|
1 | |
|
person
Cowen and Company, LLC
|
Employee |
5
|
1 | |
|
person
Cowen
|
Employment recipient |
5
|
1 | |
|
person
Cowen and Company
|
Employee |
1
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2019-02-25 | N/A | Publication of Cowen Collaborative Insights report. | N/A | View |
This document is page 49 of a financial research report by Cowen Collaborative Insights, dated February 25, 2019. It analyzes the market potential for CBD-infused food and confections in the U.S., projecting sales could surpass $400 million by 2020. The document contains charts and sensitivity analyses regarding market share and revenue growth. It bears the Bates stamp HOUSE_OVERSIGHT_024865, indicating it was part of a document production for the House Oversight Committee, though the specific content is strictly market research unrelated to specific individuals.
This document is page 48 of a Cowen Collaborative Insights financial research report dated February 25, 2019. It analyzes product offerings and packaging from CBD companies 'Lord Jones' and 'Charlotte's Web' (CWEB), specifically lotions, oils, and balms. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as evidence during a congressional investigation, likely related to financial oversight, though no direct mention of Jeffrey Epstein appears on this specific page.
This document is page 46 of a market research report produced by Cowen Collaborative Insights on February 25, 2019. It analyzes the pricing segments of CBD body lotions and bath bombs, listing various brands like Mary's Nutritionals and Lord Jones. While the content is purely financial market analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024862', indicating it was part of a document production for a House Oversight Committee investigation (likely related to financial records subpoenaed in the Epstein/Deutsche Bank probe), though the page itself contains no direct references to Epstein.
A page from a Cowen financial research report dated February 25, 2019, analyzing the U.S. Beauty industry and specifically projecting growth for CBD beauty products. It includes charts forecasting sales growth through 2020. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though the page itself contains no direct references to Jeffrey Epstein or illicit activity.
This document is page 43 of a Cowen Collaborative Insights market research report dated February 25, 2019. It visually analyzes four CBD/hemp-infused products: Recess sparkling water, Sprig soda, Reliva recovery shots, and Willie's Remedy coffee. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it is part of a larger collection of documents subpoenaed or reviewed by the House Oversight Committee.
A page from a Cowen market research report dated February 25, 2019, analyzing the CBD beverage market. The document includes data on price segmentation of various CBD beverage brands and demographic statistics regarding consumer usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation.
This document is page 41 of a Cowen Collaborative Insights research report dated February 25, 2019, analyzing the beer market. It focuses on the growth of Hard Seltzer and the potential revenue opportunities for CBD-infused beer, projecting market values up to 2020. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024857) and is digitally watermarked for Michael Cella.
This document is page 39 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the market potential for CBD-infused bottled water in the U.S., utilizing Google Trends and Nielsen sales data to project revenue growth through 2020. The document bears the Bates stamp HOUSE_OVERSIGHT_024855 and is watermarked for Michael Cella at Cowen.
This document is page 37 of a Cowen Collaborative Insights market research report dated February 25, 2019. It visually compares four CBD topical products from companies Mary's Medicinals, Curaleaf, Highline, and Reliva, noting packaging and pricing strategies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a Congressional investigation.
This document is page 36 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the CBD topical market, detailing price segments (Super Premium to Value) and consumer demographics (age, gender, income). While the document bears a 'HOUSE_OVERSIGHT_024852' Bates stamp, indicating it is part of a government investigation (potentially related to the Epstein case files via subpoenaed financial records), the content on this specific page is purely market research regarding CBD products and does not explicitly mention Epstein or his associates.
This document is page 35 of a financial research report produced by Cowen on February 25, 2019, analyzing the U.S. CBD market, specifically focusing on 'Topicals.' The report projects the topical CBD market to grow to $1.5 billion by 2020. The document bears a 'HOUSE_OVERSIGHT_024851' Bates stamp, indicating it was obtained during a House Oversight Committee investigation, though the content of this specific page is purely financial market analysis and does not explicitly mention Jeffrey Epstein.
This document is page 34 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the packaging and pricing of CBD gummy products from four different companies: CV Sciences, Green Roads, Highline Wellness, and cbdMD. The document bears a 'HOUSE_OVERSIGHT_024850' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though the content appears to be standard equity research unrelated to criminal activity.
This document is page 32 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the packaging and market positioning of four CBD/Hemp capsule brands: Mary's Medicinals, Charlotte's Web, Elixinol, and Lazarus Naturals. The page contains the Bates stamp HOUSE_OVERSIGHT_024848, indicating it was part of a document production to the House Oversight Committee, though the visible content focuses solely on commercial cannabis products.
This document is page 31 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. It analyzes the pricing segments of various CBD capsule brands and presents demographic data (gender, age, income) regarding CBD capsule usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely as part of a larger cache of financial or corporate records.
This document is page 30 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the packaging and market positioning of four CBD brands: Lord Jones, CV Sciences (Plus CBD Oil), Papa & Barkley, and Reliva. The document bears the Bates stamp HOUSE_OVERSIGHT_024846, indicating it was obtained during a US House Oversight Committee investigation, though the specific page content relates strictly to commercial CBD products and contains no direct mention of Jeffrey Epstein.
This document is page 29 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019, analyzing the CBD tincture market. It presents data on price segmentation among competitors (such as Lord Jones and Lazarus) and consumer demographics regarding tincture usage. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024845', indicating it was obtained during a House Oversight Committee investigation, likely as part of a larger cache of documents from a financial institution, though the content itself is strictly market research.
This document is page 28 of a financial research report produced by Cowen on February 25, 2019, analyzing the Nutraceuticals market. It specifically focuses on U.S. CBD sales projections following the 2018 Farm Bill, estimating $2.4 billion in revenue by 2020. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024844), suggesting it was part of a subpoena or discovery process involving Cowen.
This document is page 27 of a Cowen Collaborative Insights financial report dated February 25, 2019. The content is a market analysis of the CBD (Cannabidiol) industry, breaking down price per milligram across various product categories such as tinctures, gummies, and beauty products. While the content itself is strictly financial research regarding consumer staples, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024843', indicating it was part of a document production for a US House Oversight Committee investigation.
This document is page 26 of a market research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It analyzes the CBD and Hemp industry through the lens of Instagram metrics (followers, posts, likes) for January 2019, comparing emerging brands like CBDFX and Lord Jones against established public companies. While the document bears a 'HOUSE_OVERSIGHT_024842' stamp, suggesting it was part of a document production for a congressional investigation (potentially related to financial probes involving Epstein or Deutsche Bank), the content itself is strictly commercial market analysis with no direct mention of Jeffrey Epstein.
This document is page 25 of a market research report by Cowen Collaborative Insights, dated February 25, 2019. It analyzes the growth of Hemp Oil products on Amazon (increasing from ~5,000 to >20,000 between 2013 and 2019) and provides demographic data on CBD supplement usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation, though the content itself is strictly market data regarding CBD and does not mention Epstein directly.
This document is page 24 of a Cowen Collaborative Insights research report dated February 25, 2019, analyzing the U.S. CBD market. It presents data suggesting the market size is approaching $2 billion based on consumer surveys and increasing Google search trends for CBD products like gummies, creams, and oils. The document bears a House Oversight Bates stamp (024840), indicating it was part of a document production to Congress, though no direct mention of Jeffrey Epstein appears on this specific page.
This document is page 23 of a financial research report produced by Cowen regarding the 'Separations Technology and Market' (Chromatography). It details the technical differences between Liquid Chromatography (LC) and Gas Chromatography (GC), their usage with Mass Spectrometry, and provides market estimates and share data for 2014-2018. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced during a congressional investigation, but the text itself contains technical scientific market data and no direct references to Jeffrey Epstein.
This document is page 21 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing a strategic partnership between Cronos Group and Ginkgo Bioworks valued at $122MM. The text details the financial structure of the deal, including R&D funding and equity milestones for producing specific cannabinoids like THC and CBD. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, likely included in a larger cache of internal financial documents.
This document is page 20 of a Cowen 'Collaborative Insights' financial research report dated February 25, 2019. It details the scientific process of biosynthetic cannabinoid production via fermentation and highlights a specific February 2019 business deal where Amyris signed a partnership valued at up to $255 million with an 'undisclosed partner.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the U.S. House Oversight Committee.
This document is page 19 of a Cowen 'Collaborative Insights' report dated February 25, 2019. It details the industry landscape for synthetic biology cannabinoid production, listing specific companies such as Ginkgo Bioworks and Amyris with brief descriptions of their technologies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though no direct mention of Jeffrey Epstein appears on this specific page.
Analysis of cannabinoid-based drugs, specifically GW's Epidiolex and Zynerba's ZYN002, including clinical trial data.
Research report distribution intended for michael.cella@cowen.com
Market analysis of corn, soybeans, and hemp production economics.
Financial report on Synthetic Biology and Cannabinoid production.
Financial report on Synthetic Biology and Cannabinoid production.
Research report regarding GW Pharma and Epidiolex efficacy/safety data.
Research report regarding GW Pharma and CBD clinical trials.
Market research report regarding CBD/Cannabis regulations in Europe.
Market research report regarding CBD usage statistics and market sizing.
Financial analysis of the U.S. Beauty and CBD Beauty markets.
Market analysis of CBD vapor and e-cigarette sales projections.
Market research report regarding CBD capsule providers distributed to michael.cella@cowen.com
Market analysis of CBD confection and bar products, including price segmentation.
Investment report distribution restricted to michael.cella@cowen.com
Analysis of Epidiolex drug trials and investor sentiment regarding efficacy with/without clobazam.
Financial analysis of cannabis and tobacco companies.
Market research report regarding CBD capsule pricing and demographic usage statistics.
Market analysis of CBD gummy pricing and packaging.
This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited.
Financial report regarding cannabis market partnerships.
Industry report on Synthetic Biology Cannabinoid Companies.
Market research report regarding hemp and CBD in textiles.
Markey analysis of CBD topicals distributed to internal employee.
Analysis of international drug conventions and WHO recommendations regarding CBD regulation.
Industry analysis regarding CBD-infused textiles and partnerships.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity